Page 52 - Read Online

Page 22 of 23 ALHulais et al. J Cancer Metastasis Treat 2019;5:3 I http://dx.doi.org/10.20517/2394-4722.2018.71

angiogenesis in human gastric carcinoma. Int J Oncol 2003;23:1317-22.
178. Yu HG, Li JY, Yang YN, Luo HS, Yu JP, et al. Increased abundance of cyclooxygenase-2 correlates with vascular endothelial growth
factor-A abundance and tumor angiogenesis in gastric cancer. Cancer Lett 2003;195:43-51.
179. Gallo O, Franchi A, Magnelli L, Sardi I, Vannacci A, et al. Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck
cancer. Implications for tumor angiogenesis and metastasis. Neoplasia 2001;3:53-61.
180. Chu J, Lloyd FL, Trifan OC, Knapp B, Rizzo MT. Potential involvement of the cyclooxygenase-2 pathway in the regulation of tumor-
associated angiogenesis and growth in pancreatic cancer. Mol Cancer Ther 2003;2:1-7.
181. Yoshida S, Amano H, Hayashi I, Kitasato H, Kamata M, et al. COX-2/VEGF-dependent facilitation of tumor-associated angiogenesis and
tumor growth in vivo. Lab Invest 2003;83:1385-94.
182. Gately S, Li WW. Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy. Semin Oncol 2004;31:2-11.
183. Gungor H, Ilhan N, Eroksuz H. The effectiveness of cyclooxygenase-2 inhibitors and evaluation of angiogenesis in the model of
experimental colorectal cancer. Biomed Pharmacother 2018;102:221-9.
184. Kurtova AV, Xiao J, Mo Q, Pazhanisamy S, Krasnow R, et al. Blocking PGE2-induced tumour repopulation abrogates bladder cancer
chemoresistance. Nature 2015;517:209-13.
185. Pang LY, Hurst EA, Argyle DJ. Cyclooxygenase-2: a role in cancer stem cell survival and repopulation of cancer cells during therapy. Stem
Cells Int 2016;2016:2048731.
186. Liu B, Qu L, Yan S. Cyclooxygenase-2 promotes tumor growth and suppresses tumor immunity. Cancer Cell Int 2015;15:106.
187. Greenhough A, Smartt HJ, Moore AE, Roberts HR, Williams AC, et al. The COX-2/PGE2 pathway: key roles in the hallmarks of cancer
and adaptation to the tumour microenvironment. Carcinogenesis 2009;30:377-86.
188. Sobolewski C, Cerella C, Dicato M, Ghibelli L, Diederich M. The role of cyclooxygenase-2 in cell proliferation and cell death in human
malignancies. Int J Cell Biol 2010;2010:215158.
189. Park GB, Jin DH, Kim D. Sequential treatment with celecoxib and bortezomib enhances the ER stress-mediated autophagy-associated cell
death of colon cancer cells. Oncol Lett 2018;16:4526-36.
190. Kobayashi K, Omori K, Murata T. Role of prostaglandins in tumor microenvironment. Cancer Metastasis Rev 2018;37:347-54.
191. Wojdasiewicz P, Poniatowski LA, Szukiewicz D. The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of
osteoarthritis. Mediators Inflamm 2014;2014:561459.
192. Zelenay S, van der Veen AG, Bottcher JP, Snelgrove KJ, Rogers N, et al. Cyclooxygenase-dependent tumor growth through evasion of
immunity. Cell 2015;162:1257-70.
193. Pritchard R, Rodriguez-Enriquez S, Pacheco-Velazquez SC, Bortnik V, Moreno-Sanchez R, et al. Celecoxib inhibits mitochondrial O2
consumption, promoting ROS dependent death of murine and human metastatic cancer cells via the apoptotic signalling pathway. Biochem
Pharmacol 2018;154:318-34.
194. Ralph SJ, Pritchard R, Rodriguez-Enriquez S, Moreno-Sanchez R, Ralph RK. Hitting the Bull’s-Eye in metastatic cancers-NSAIDs elevate
ROS in mitochondria, inducing malignant cell death. Pharmaceuticals (Basel) 2015;8:62-106.
195. Pacheco-Velazquez SC, Robledo-Cadena DX, Hernandez-Resendiz I, Gallardo-Perez JC, Moreno-Sanchez R, et al. Energy metabolism
drugs block triple negative breast metastatic cancer cell phenotype. Mol Pharm 2018;15:2151-64.
196. Meng X, Zhang Q, Zheng G, Pang R, Hua T, et al. Doxorubicin combined with celecoxib inhibits tumor growth of medullary thyroid
carcinoma in xenografted mice. Oncol Lett 2014;7:2053-8.
197. Chen C, Xu W, Wang CM. Combination of celecoxib and doxorubicin increases growth inhibition and apoptosis in acute myeloid leukemia
cells. Leuk Lymphoma 2013;54:2517-22.
198. van Wijngaarden J, van Beek E, van Rossum G, van der Bent C, Hoekman K, et al. Celecoxib enhances doxorubicin-induced cytotoxicity in
MDA-MB231 cells by NF-kappaB-mediated increase of intracellular doxorubicin accumulation. Eur J Cancer 2007;43:433-42.
199. Hashitani S, Urade M, Nishimura N, Maeda T, Takaoka K, et al. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs
by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines. Int J Oncol 2003;23:665-72.
200. Chu TH, Chan HH, Hu TH, Wang EM, Ma YL, et al. Celecoxib enhances the therapeutic efficacy of epirubicin for Novikoff hepatoma in
rats. Cancer Med 2018;7:2567-80.
201. Lin J, Hsiao PW, Chiu TH, Chao JI. Combination of cyclooxygenase-2 inhibitors and oxaliplatin increases the growth inhibition and death
in human colon cancer cells. Biochem Pharmacol 2005;70:658-67.
202. Kuhar M, Imran S, Singh N. Celecoxib enhances the chemotherapeutic response of cisplatin and TNF-alpha in SiHa cells through reactive
oxygen species-mediated mitochondrial pathway. Int J Biomed Sci 2007;3:176-84.
203. Liu B, Shi ZL, Feng J, Tao HM. Celecoxib, a cyclooxygenase-2 inhibitor, induces apoptosis in human osteosarcoma cell line MG-63 via
down-regulation of PI3K/Akt. Cell Biol Int 2008;32:494-501.
204. Kim SH, Kim SH, Song YC, Song YS. Celecoxib potentiates the anticancer effect of cisplatin on vulvar cancer cells independently of
cyclooxygenase. Ann N Y Acad Sci 2009;1171:635-41.
205. Li WZ, Wang XY, Li ZG, Zhang JH, Ding YQ. Celecoxib enhances the inhibitory effect of cisplatin on Tca8113 cells in human tongue
squamous cell carcinoma in vivo and in vitro. J Oral Pathol Med 2010;39:579-84.
206. Xu HB, Shen FM, Lv QZ. Celecoxib enhanced the cytotoxic effect of cisplatin in chemo-resistant gastric cancer xenograft mouse models
through a cyclooxygenase-2-dependent manner. Eur J Pharmacol 2016;776:1-8.
207. Irie T, Tsujii M, Tsuji S, Yoshio T, Ishii S, et al. Synergistic antitumor effects of celecoxib with 5-fluorouracil depend on IFN-gamma. Int J
Cancer 2007;121:878-83.
208. Zhao S, Cai J, Bian H, Gui L, Zhao F. Synergistic inhibition effect of tumor growth by using celecoxib in combination with oxaliplatin.
Cancer Invest 2009;27:636-40.
209. Chu TH, Chan HH, Kuo HM, Liu LF, Hu TH, et al. Celecoxib suppresses hepatoma stemness and progression by up-regulating PTEN.
Oncotarget 2014;5:1475-90.